Todd J. Sullivan

High Affinity InhA Inhibitors with Activity against Drug-Resistant Strains of <i>Mycobacterium tuberculosis</i>

Todd J. Sullivan, J.J. Truglio, Melissa E. Boyne et al. · ACS Chemical Biology · 2006 · 232 citations · Full text

Mtb Results, Tuberculosis Prevention, Antimicrobial Chemotherapy +17

Inhibition of the Bacterial Enoyl Reductase FabI by Triclosan:  A Structure−Reactivity Analysis of FabI Inhibition by Triclosan Analogues

Sharada Sivaraman, Todd J. Sullivan, Francis Johnson et al. · Journal of Medicinal Chemistry · 2004 · 109 citations

Triclosan Analogues, Biosynthesis, Engineering +14

Synthesis and in vitro antimycobacterial activity of B-ring modified diaryl ether InhA inhibitors

Christopher W. am Ende, Susan E. Knudson, Nina Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 72 citations · Full text

Medicinal Chemistry, Pharmaceutical Chemistry, Antifungal Agent +11

Mechanism and Inhibition of saFabI, the Enoyl Reductase from<i>Staphylococcus aureus</i>

Hua Xu, Todd J. Sullivan, Jun‐ichiro Sekiguchi et al. · Biochemistry · 2008 · 65 citations · Full text

Targeting Fatty Acid Biosynthesis for the Development of Novel Chemotherapeutics against <i>Mycobacterium tuberculosis</i> : Evaluation of A-Ring-Modified Diphenyl Ethers as High-Affinity InhA Inhibitors

Melissa E. Boyne, Todd J. Sullivan, Christopher W. amEnde et al. · Antimicrobial Agents and Chemotherapy · 2007 · 57 citations · Full text

Antibiotic Adjuvant, High-affinity Inha Inhibitors, Antimicrobial Chemotherapy +17